HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of microcystic lymphangioma with OK-432 after intralesional excision.

Abstract
Microcystic lymphangioma is difficult to treat with sclerotherapy or surgical resection alone. It is impossible to inject sclerosing agents into multiple cysts and surgical resection may sacrifice neighboring organs. We report a case of clinically regressed microcystic lymphangioma by sclerotherapy with OK-432 after intralesional excision. This is an alternative effective method in the treatment of microcystic lymphangioma. However, because histological examination revealed remaining lymphangioma, the possibility of recurrence remains.
AuthorsTetsuji Yabe, Makoto Takahashi
JournalThe Journal of dermatology (J Dermatol) Vol. 36 Issue 1 Pg. 60-2 (Jan 2009) ISSN: 0385-2407 [Print] England
PMID19207439 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Picibanil
Topics
  • Adult
  • Combined Modality Therapy
  • Humans
  • Leg
  • Lymphangioma (pathology, surgery, therapy)
  • Male
  • Picibanil (therapeutic use)
  • Sclerotherapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: